Working… Menu

CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01760811
Recruitment Status : Unknown
Verified January 2013 by popovtzer aron, Rabin Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : January 4, 2013
Last Update Posted : January 4, 2013
Kaplan Medical Center
Meir Medical Center
Information provided by (Responsible Party):
popovtzer aron, Rabin Medical Center

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2015
Estimated Study Completion Date : December 2017